MetS
(n=60)
No MetS (n=62) p-value p-valuea
VLDL particle concentration (nmol/L) 74.7 (58.7-96.9) 58.5 (39.8-86.4) <0.001 0.001
Large VLDL
(nmol/L)
9.7 (5.3-14.3) 2.7 (1.0-5.3) <0.001 <0.001
Medium VLDL
(nmol/L)
37.8 (22.4-44.3) 20.9 (11.0-40.0) 0.001 <0.001
Small VLDL
(nmol/L)
27.7 (16.8-43.4) 34.0 (21.0-44.7) 0.32 <0.001
LDL particle concentration (nmol/L) 1342 (1095-1530) 1077 (922-1333) <0.001 <0.001
IDL
(nmol/L)
210 (135-258) 191 (141-241) 0.66 0.73
Large LDL
(nmol/L)
404 (288-597) 503 (435-639) 0.047 0.11
Small LDL
(nmol/L)
715 (481-923) 358 (246-532) <0.001 <0.001
HDL particle concentration (μmol/L) 32.5 (28.7-37.1) 34.3 (31.7-36.4) 0.12 0.071
Large HDL
mol/L)
3.1 (1.93-5.4) 6.1 (3.4-8.5) <0.001 <0.001
Medium HDL
mol/L)
10.6 (6.6-14.0) 12.4 (9.5-15.6) 0.006 0.030
Small HDL
(μmol/L)
18.3 (15.6-21.4) 15.3 (12.5-18.5) 0.001 0.016
Data in median (interquartile range). IDL: intermediate density lipoproteins. ap-value: p-value after adjustment for age, sex and diabetes status.
Table 2: Very low density lipoprotein (VLDL), low density lipoprotein (LDL) and high density lipoprotein (HDL) subfraction characteristics in 60 subjects with and in 62 subjects without metabolic syndrome (MetS).